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1. Introduction
  The genus mycobacteria comprises two well known 
pathogenic species of Mycobacterium tuberculosis (M. 
tuberculosis) (MTB) and Mycobacterium leprae (M. leprae) 
and majority of nontuberculous mycobacteria (NTM), 
some with potential capacity of causing disease such as 
Mycobacterium avium (M. avium) complex (MAC).
  The conditions lead to immunodeficiency, make the 
individuals predispose to mycobacterial diseases[1]. The 
human immunodeficiency virus (HIV) pandemic has 
increased the burden of tuberculosis (TB), so infections with 
mycobacteria are frequent in individuals with AIDS[2]. MTB 
and HIV infections are two major public health problems in 
many parts of the world, particularly in many developing 
counties[3,4]. TB is the most common opportunistic disease 
and cause of the death for those infected with HIV[5]. 
Similarly, HIV infection is one of the most important risk 
factors that promotes progression of latent TB infection 
to active TB disease in people with MTB infection[6,7]. 
The lifetime risk of tuberculosis in immune-competent 
persons is 5% to 10%, but in HIV positive individuals, 
there is a 5% to 15% annual risk of developing active TB 
disease[6,8]. After AIDS epidemic, NTM especially M. avium 
complex, have increasingly been reported in these severely 
immunocompromised patients[9,10]. Not infrequently, 
such patients will also have multiple infections with 
MTB, M. avium and others[11,12]. These infections are 
usually disseminated and have been shown to contribute 
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significantly to the morbidity of AIDS patients[13]. The 
World Health Organization (WHO) estimates that there are 
almost 13.7 million people living with tuberculosis and that 
the disease kills more young people and adults than any 
other infectious disease in the world. A total of about 1.77 
million people died of tuberculosis in 2007 including 456 000 
patients infected with HIV[14].
  The incidence of TB in patients with HIV infection is 
nearly 500 times higher than in the general population[12]. 
Demonstration of acid-fast bacilli (AFB) is the most 
commonly practiced method of diagnosing TB in the world 
over. However, except lymph node and pulmonary TB, 
obtaining an appropriate clinical sample is a difficult 
task. Moreover, the problem is that a large proportion of 
patients with pulmonary TB co-infected with HIV may not 
be excreting AFB in their sputum[15]. So application of more 
sophisticated techniques such as polymerase chain reaction 
(PCR) will provide more accurate information of frequency of 
mycobacterial infections in AIDS patients.
  To our knowledge, there are a few retrospective surveys in 
our country about the prevalence of mycobacterial infections 
in AIDS patients. These are limited to reports of the AFB 
results from tuberculosis reference centers and the subject 
has not been systematically investigated. Therefore, in the 
present study, we aimed to estimate the prevalence of MTB 
and M. avium infections in HIV-positive patients suspected 
to have pulmonary and extrapulmonary mycobacterial co-
infection using PCR technique. We believe that the results 
of this study can provide useful information regarding the 
epidemiology of these infections in the region of study.
2. Materials and methods
2.1. Study population and setting
  In total 50 samples were taken from HIV positive 
patients admitted to the Infectious Diseases ward of Razi 
teaching hospital of Ahvaz Jundishapur University of 
Medical Sciences, Ahvaz, Southwestern Iran, from April 
2010 to March 2011. All the patients were suspected of 
having mycobacterial infection. The study was approved 
by Institutional Ethics Committee after submission of 
preliminary proposal of the study.
  The demographic information including age, sex and 
underlying disorders were collected from each patient and 
HIV infection was diagnosed on the basis of enzyme-linked 
immunosorbent assay (ELISA) and western blotting. Clinical 
and radiographic features were the basis of suspicion 
of tuberculosis in patients. Patients undergone anti 
mycobacterial therapy prior to admission, were excluded 
from the study. Various samples including sputum, pleural 
fluid and CSF were collected and were immediately 
transferred to the Infectious and Tropical Diseases Research 
Center of the University, where the initial processing and 
DNA extraction performed on the samples, using standard 
extraction and purification kit (Cinnagen Co., Tehran, Iran).
2.2. PCR assay for M. tuberculosis
  The amplification was performed as previously described 
using a set of Mycobacterium tuberculosis-specific primers 
of IS1 and IS2, which amplifies a 123 bp of the IS6110-gene 
fragment[16]. In brief, the reaction volume (25 毺L) composed 
of 50 mmol KCl, 10 mmol Tris-HCl (pH 8.3), 1.5 mmol MgCl2, 
0.2 mmol of each deoxynucleotide triphosphate, 0.5 毺mol 
of each primer, 1 units of Taq polymerase (Cinnagen Co., 
Tehran,Iran), 14 毺L of sterile distilled water and 5 毺L of 
processed DNA sample. Amplification was done with a four-
stage protocol on a Techgene thermocycler (UK) using the 
program as below:
  An initial denaturation of 94 ℃ for 5 min followed by 30 
cycles of 94 ℃ for 1 min, 68 ℃ for 1 min and 72 ℃ for 1 min 
and final extension of 72 ℃ for 5 min. For analysis of the 
amplified products, they were loaded on a 2% agarose gel 
containing 0.5 mg/mL ethidium bromide in electrophoresis 
and photographed by using the gel documentation system.
2.3. PCR assay for M. avium complex
  The primers used were those reported earlier as mig upper, 
5’-CCC GTT CAA CGT CAA CTT CC-3’; and mig lower, 5’-
GGG CTC GCC GGT CAT CAG GT-3’. These primers amplify 
a 737 bp fragment within the coding region of the gene[17]. 
DNA amplification was performed in the same manner as 
described above for MTB, using a 25 毺L reaction mixture 
containing all the buffer components and enzyme, plus 10 
pmol of each primer and 1 ng DNA template. The cycling 
conditions were as follows: initial denaturation at 95 曟 for 
5 min and 30 cycles of 30 s of denaturation at 95 曟 and 
2 min of annealing and extension at 68 曟, followed by 
a 5 min final extension at 72 曟. The PCR products were 
loaded on a 2% agarose gel containing 0.5 mg/mL ethidium 
bromide in electrophoresis, with a 1 kb DNA ladder used 
for size determination, and photographed by using the gel 
documentation system.
3. Results
  The study patients comprised of 45 male (90%) and 5 
female (10%). The patients’ age ranges were 22 to 36 with the 
mean of 30. The majority of patients (74%), were drug user, 
with 34 (68%) male and 3 (6%) female and the rest were HIV 
positive non-drug users (26%). Among the patients, there 
were 8 HCV positive (16%), 16 HBV positive (32%) and 8 with 
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HCV and HBV infection simultaneously (16%).
  From 50 samples processed, 45 were sputum (90%), 3 
pleural fluid (6%) and 2 CSF (4%). In total, 8 (16%) were 
culture positive, 7 had positive acid fast staining (14 %) 
and 13 samples (26%) were positive using PCR technique. 
Figure 1 represents the PCR amplification for samples 
positive for M. avium yieled a 373 bp fragment. All the 
positive samples were sputum and belonged to patients 
with pulmonary infection. Of these, 9 were positive for MTB 
(69.2%) and 4 were identified as M. avium (30.8%), which 2 




Figure 1. Agarose gel electrophoresis of PCR assay for the 
identification of mig gene of M. avium.
M: DNA size marker; 1: negative control; 2: Positive control; 3-6 
positive isolates.
  All the patients infected with MTB were male drug users 
(18%), 4 were positive for HCV (8%), 1 was HBV positive 
(2%), and 2 were simultanous HCV and HBV positive (4%). 
Among 4 patients positive for M. avium, 2 were drug user 
(50%), 1 was infected with HCV (25%) and 1 was infected 
with both HCV and HBV (25%). The other 2 patients with 
mixed mycobacterial infections were nor drug user, neither 
had viral infection.
4. Discussion
  The increasing rate of HIV infection in many countries has 
had an impact on TB epidemiology. While TB prevalence has 
remained stable, TB incidence continues to rise, especially 
in countries most severely affected by the HIV epidemic 
as well as those facing political turmoil, migration, poverty 
and unemployment and where intravenous drug abuse is 
rampant[7].
  In our study the rate of mycobacterial infection among HIV 
positive patients was 26% by PCR technique. This rate was 
reported as 38.5% in one study from India, a country with 
high burden of AIDS[18]. Obviously we could expect a higher 
rate of HIV-TB co-infection in such studies[12].
  The majority (90%) of patients entered our study were male. 
The findings were in agreement with other studies showing 
the men as predominance of HIV positive patients[12,19]. 
However in one study, the male to female ratio was reported 
as 1:1.2 among 120 HIV-infected patients in northern 
Tanzania[20-26]. This reflects that the rate of gender- 
dependant HIV infection is different in various geographical 
parts. Besides, our HIV cases were predominantly drug users 
and this shows the high prevalence of HIV among drug users, 
as previously reported from other parts of the world[1,13,27].
  Most of our suspected HIV-positive patients had 
pulmonary involvement, comprised all of positive patients 
for mycobacterial infections. Of course the rate of isolated 
mycobacterial infection was lower compared to reports 
from other parts of the world[20]. Despite the selection 
of preferably HIV-positive patients before antibiotic 
therapy, a few included patients, probably had taken some 
medications with no clear history of antibiotic therapy in 
their first admission. This may explains the lower rate of 
mycobacterial isolation in culture and disagreement of PCR 
results (26%) with culture (16%) and acid fast staining (14%) 
in present study. Besides, the lower rate of AFB by staining, 
may be due to other respiratory tract infections common 
in HIV positive patients as has been explained in a recent 
study[28]. Even in the study of Palmieri et al, they reported 
negative AFB staining among their HIV positive patients co-
infected with TB[29].
  We could not find any extrapulmonary mycobacterial 
infection among the screened HIV positive patients. The 
lower sample size in present study due to restriction of 
duration of sampling and difficulties in sample collection 
from patients, may be an explanation for lack of positive 
extrapulmonay co-infection in present study.
  MTB was identified in the rate of 69.2% among positive 
samples and this shows the higher involvement of MTB 
in such patients compared to MAC infection (30.8%) in 
our study. For being ensure that all M. avium cases are 
identified by PCR, we used primers based on the mig gene. 
The mig gene is the only well-characterized virulence factor 
identified in MAC as reported earlier[17]. In a similar study, 
various molecular methods were used to evaluate organisms 
in the MAC, in patients who are immune-compromised, such 
as those with AIDS. By using PCR assay, which amplifies 
the mig gene, they showed that 85% of the isolates from 
HIV-positive patients were M. avium. They identified 92 
M. avium isolates, 75 of which were from HIV-positive 
patients[11].
  There were some patients with infections of HBV and HCV 
in our study which is common in HIV-positive patients 
as earlier stated[28]. However due to low rate of such co-
infection, we could not find a significant correlation between 
these viral infections and mycobacterial disease in present 
study.
  In conclusion, the PCR showed the highest detection rate 
(26%) of mycobacteria compared with culture and acid fast 
staining. The majority of infections were with MTB (18%) and 
this shows the importance of this mycobacterial co-infection 
in HIV positive patients in the region of study.
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